The search for host genetic factors of HIV/AIDS pathogenesis in the post-genome era: Progress to date and new avenues for discovery

Current HIV/AIDS Reports

Volumn 8, Issue 1, 2011, Pages 38-44

  Aouizerat, Bradley E ^c   Pearce, C Leigh ^a   Miaskowski, Christine ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE

Author keywords

Disease progression; Genome wide association study; GWAS; Single nucleotide polymorphism; SNP; Viral load set point

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CHEMOKINE RECEPTOR CXCR6; HLA ANTIGEN; HLA ANTIGEN P5; HLA B ANTIGEN; HLA C ANTIGEN; HOMEODOMAIN PROTEIN; PROSPERO HOMEOBOX 1 PROTEIN; PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN ARGININE METHYLTRANSFERASE 6; RIBOSOMAL PROTEIN S6 KINASE ALPHA 6; RYANODINE RECEPTOR 3; S6 KINASE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR SOX5; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR ASSOCIATED PROTEIN 1; UNCLASSIFIED DRUG; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ATHEROSCLEROSIS; CHRONIC KIDNEY DISEASE; COMORBIDITY; DISEASE COURSE; DNA SEQUENCE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENOME ANALYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOST; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL RESEARCH; MOLECULAR PATHOLOGY; PHARMACOGENOMICS; PROTEIN PROTEIN INTERACTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS LOAD; VIRUS PATHOGENESIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; DISEASE PROGRESSION; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HIV; HUMANS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SYSTEMS BIOLOGY; VIRAL LOAD;

EID: 79952699573     PISSN: 15483568     EISSN: 15483576     Source Type: Journal    
DOI: 10.1007/s11904-010-0065-1     Document Type: Review

References (38)

1. An P, Winkler CA. Host genes associated with HIV/AIDS: advances in gene discovery. Trends Genet.26(3):119-131. This is an excellent review of host genetic studies of HIV/AIDS. In addition to review of the first five GWAS of HIV/AIDS, the review provides an excellent overview of candidate gene studies and identifies areas for future research.
2. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR. Identification of a major coreceptor for primary isolates of HIV-1. Nature. 1996;381(6584):661-666. (Pubitemid 26197679)
3. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 1996;381(6584):667-673. (Pubitemid 26197680)
4. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 1996;382(6593):722-725.
5. Dalmasso C, Carpentier W, Meyer L, Rouzioux C, Goujard C, Chaix ML, Lambotte O, Avettand-Fenoel V, Le Clerc S, de Senneville LD, Deveau C, Boufassa F, Debre P, Delfraissy JF, Broet P, Theodorou I, Association AGW. Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study. PLoS One. 2008;3(12):e3907.
6. Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, Cirulli ET, Urban TJ, Zhang K, Gumbs CE, Smith JP, Castagna A, Cozzi-Lepri A, De Luca A, Easterbrook P, Gunthard HF, Mallal S, Mussini C, Dalmau J, Martinez-Picado J, Miro JM, Obel N, Wolinsky SM, Martinson JJ, Detels R, Margolick JB, Jacobson LP, Descombes P, Antonarakis SE, Beckmann JS, O'Brien SJ, Letvin NL, McMichael AJ, Haynes BF, Carrington M, Feng S, Telenti A, Goldstein DB, Immunology NCfHAV. Common genetic variation and the control of HIV-1 in humans. PLoS Genet. 2009;5(12):e1000791.
7. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, Zhang K, Gumbs C, Castagna A, Cossarizza A, Cozzi-Lepri A, De Luca A, Easterbrook P, Francioli P, Mallal S, Martinez-Picado J, Miro JM, Obel N, Smith JP, Wyniger J, Descombes P, Antonarakis SE, Letvin NL, McMichael AJ, Haynes BF, Telenti A, Goldstein DB. A whole-genome association study of major determinants for host control of HIV-1. Science. 2007;317 (5840):944-947. This is the first GWAS of HIV/AIDS. The study demonstrated the feasibility and utility of host genome searches.
8. Herbeck JT, Gottlieb GS, Winkler CA, Nelson GW, An P, Maust BS, Wong KG, Troyer JL, Goedert JJ, Kessing BD, Detels R, Wolinsky SM, Martinson J, Buchbinder S, Kirk GD, Jacobson LP, Margolick JB, Kaslow RA, O'Brien SJ, Mullins JI. Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS. J Infect Dis. 201(4):618-626.
9. Joubert BR, Lange EM, Franceschini N, Mwapasa V, North KE, Meshnick SR, the NCfHIVAVI. A whole genome association study of mother-to-child transmission of HIV in Malawi. Genome Med. 2(3):17.
10. Le Clerc S, Limou S, Coulonges C, Carpentier W, Dina C, Taing L, Delaneau O, Labib T, Sladek R, Group AG, Deveau C, Guillemain H, Ratsimandresy R, Montes M, Spadoni JL, Therwath A, Schachter F, Matsuda F, Gut I, Lelievre JD, Levy Y, Froguel P, Delfraissy JF, Hercberg S, Zagury JF. Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03). J Infect Dis. 2009;200(8):1194-1201.
11. Limou S, Coulonges C, Herbeck JT, van Manen D, An P, Le Clerc S, Delaneau O, Diop G, Taing L, Montes M, van't Wout AB, Gottlieb GS, Therwath A, Rouzioux C, Delfraissy JF, Lelievre JD, Levy Y, Hercberg S, Dina C, Phair J, Donfield S, Goedert JJ, Buchbinder S, Estaquier J, Schachter F, Gut I, Froguel P, Mullins JI, Schuitemaker H, Winkler C, Zagury JF. Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS. J Infect Dis. 202(6):908-915. This is a GWAS of the LTNP phenotype that identified a novel but mechanistically sound locus for the trait. The refinement of the non-progression phenotype by exclusion of elite controllers highlighted the value of exploring other HIV/AIDS phenotypes and in applying new knowledge to refine phenotypes.
12. Limou S, Le Clerc S, Coulonges C, Carpentier W, Dina C, Delaneau O, Labib T, Taing L, Sladek R, Deveau C, Ratsimandresy R, Montes M, Spadoni JL, Lelievre JD, Levy Y, Therwath A, Schachter F, Matsuda F, Gut I, Froguel P, Delfraissy JF, Hercberg S, Zagury JF, Group AG. Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J Infect Dis. 2009;199(3):419-426.
13. Pelak K, Goldstein DB, Walley NM, Fellay J, Ge D, Shianna KV, Gumbs C, Gao X, Maia JM, Cronin KD, Hussain SK, Carrington M, Michael NL, Weintrob AC, Infectious Disease Clinical Research Program HIVWG, National Institute of A, Infectious Diseases Center for HIVAVI. Host determinants of HIV-1 control in African Americans. J Infect Dis. 201(8):1141-1149.
14. Siddiqui RA, Sauermann U, Altmuller J, Fritzer E, Nothnagel M, Dalibor N, Fellay J, Kaup FJ, Stahl-Hennig C, Nurnberg P, Krawczak M, Platzer M. X chromosomal variation is associated with slow progression to AIDS in HIV-1-infected women. Am J Hum Genet. 2009;85(2):228-239.
15. Catano G, Kulkarni H, He W, Marconi VC, Agan BK, Landrum M, Anderson S, Delmar J, Telles V, Song L, Castiblanco J, Clark RA, Dolan MJ, Ahuja SK. HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles. PLoS One. 2008;3(11):e3636. Careful modeling resulted in the dissection of these two tightly linked loci and provided evidence of unique contributions of each locus. Of note, the HCP5 locus was associated with progression and not delayed progression, contrary to previous report due to the strong correlation with the protective HLA-B locus.
16. Loeuillet C, Deutsch S, Ciuffi A, Robyr D, Taffe P, Munoz M, Beckmann JS, Antonarakis SE, Telenti A. In vitro whole-genome analysis identifies a susceptibility locus for HIV-1. PLoS Biol. 2008;6(2):e32.
17. Cantor RM, Lange K, Sinsheimer JS. Prioritizing GWAS results: A review of statistical methods and recommendations for their application. Am J Hum Genet. 86(1):6-22.
18. Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, Young M, Greenblatt R, Sacks H, Feldman J. The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology. 1998;9(2):117-125.
19. van Loggerenberg F, Mlisana K, Williamson C, Auld SC, Morris L, Gray CM, Abdool Karim Q, Grobler A, Barnabas N, Iriogbe I, Abdool Karim SS, Team CAIS. Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study. PLoS One. 2008;3(4):e1954.
20. Kircher M, Kelso J. High-throughput DNA sequencing-concepts and limitations. Bioessays. 32(6):524-536.
21. Moore JH, Asselbergs FW, Williams SM. Bioinformatics challenges for genome-wide association studies. Bioinformatics. 26(4):445-455.
22. Dickson SP, Wang K, Krantz I, Hakonarson H, Goldstein DB. Rare variants create synthetic genome-wide associations. PLoS Biol. 8(1):e1000294.
23. Bisgrove D, Lewinski M, Bushman F, Verdin E. Molecular mechanisms of HIV-1 proviral latency. Expert Rev Anti Infect Ther. 2005;3(5):805-814. (Pubitemid 41535402)
24. Muthen B, Muthen LK. Integrating person-centered and variable-centered analyses: growth mixture modeling with latent trajectory classes. Alcohol Clin Exp Res. 2000;24(6):882-891. (Pubitemid 30421740)
25. Vidal F, Gutierrez F, Gutierrez M, Olona M, Sanchez V, Mateo G, Peraire J, Vilades C, Veloso S, Lopez-Dupla M, Domingo P. Pharmacogenetics of adverse effects due to antiretroviral drugs. AIDS Rev. 12(1):15-30.
26. Bernard L, Vuagnat A, Peytavin G, Hallouin MC, Bouhour D, Nguyen TH, Vilde JL, Bricaire F, Raguin G, de Truchis P, Ghez D, Duong M, Perronne C. Relationship between levels of indinavir in hair and virologic response to highly active antiretroviral therapy. Ann Intern Med. 2002;137(8):656-659. (Pubitemid 35176098)
27. Duval X, Peytavin G, Breton G, Ecobichon JL, Descamps D, Thabut G, Leport C. Hair versus plasma concentrations as indicator of indinavir exposure in HIV-1-infected patients treated with indinavir/ritonavir combination. AIDS. 2007;21(1):106-108. (Pubitemid 44912545)
28. Gandhi M, Ameli N, Bacchetti P, Gange SJ, Anastos K, Levine A, Hyman CL, Cohen M, Young M, Huang Y, Greenblatt RM, Women's Interagency HIVS. Protease inhibitor levels in hair strongly predict virologic response to treatment. AIDS. 2009;23(4):471-478.
29. Mothe B, Perez I, Domingo P, Podzamczer D, Ribera E, Curran A, Vilades C, Vidal F, Dalmau D, Pedrol E, Negredo E, Molto J, Paredes R, Perez-Alvarez N, Gatell JM, Clotet B. HIV-1 infection in subjects older than 70: a multicenter cross-sectional assessment in Catalonia, Spain. Curr HIV Res. 2009;7(6):597-600.
30. Volberding PA, Deeks SG. Antiretroviral therapy and management of HIV infection. Lancet. 376(9734):49-62.
31. Robinson-Papp J, Simpson DM. Neuromuscular diseases associated with HIV-1 infection. Muscle Nerve. 2009;40(6):1043-1053.
32. Farrugia PM, Lucariello R, Coppola JT. Human immunodeficiency virus and atherosclerosis. Cardiol Rev. 2009;17(5):211-215.
33. Stankov MV, Behrens GM. Contribution of Inflammation to Fat Redistribution and Metabolic Disturbances in HIV-1 Infected Patients. Curr Pharm Des.
34. Levine AJ, Singer EJ, Shapshak P. The Role of Host Genetics in the Susceptibility for HIV-associated Neurocognitive Disorders. AIDS Behav. 2009;13(1):118-132. This is an excellent review of HIV-associated neurocognitive disorders. An examination of plausible candidate genes is provided.
35. Estrella MM, Fine DM. Screening for chronic kidney disease in HIV-infected patients. Adv Chronic Kidney Dis. 17(1):26-35.
36. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, Oleksyk T, McKenzie LM, Kajiyama H, Ahuja TS, Berns JS, Briggs W, Cho ME, Dart RA, Kimmel PL, Korbet SM, Michel DM, Mokrzycki MH, Schelling JR, Simon E, Trachtman H, Vlahov D, Winkler CA. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet. 2008;40(10):1175-1184.
37. Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A, Bekele E, Bradman N, Wasser WG, Behar DM, Skorecki K. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet. 128(3):345-350.
38. Shrestha S, Irvin MR, Taylor KD, Wiener HW, Pajewski NM, Haritunians T, Delaney JA, Schambelan M, Polak JF, Arnett DK, Chen YD, Grunfeld C. A genome-wide association study of carotid atherosclerosis in HIV-infected men. AIDS. 24(4):583-592.